CASI PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable
CASI PHARMACEUTICALS, INC. (CASIF) reported Increase (Decrease) in Accounts Receivable of -$11.25 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-05-15
| Period end | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|
| 2025-12-31 | -$11.25M 20-F · filed 2026-05-15 |
| 2024-12-31 | $5.79M 20-F · filed 2026-05-15 |
| 2023-12-31 | -$3.42M 20-F · filed 2026-05-15 |
| 2022-12-31 | $3.17M 20-F · filed 2025-03-31 |
| 2021-12-31 | $5.16M 20-F · filed 2024-03-28 |
| 2020-12-31 | $3.35M 20-F · filed 2023-04-26 |